Acorda and Watson to Launch Generic Zanaflex Capsules
Acorda Therapeutics announced that it has partnered with Watson Pharma to launch Tizanidine HCl capsules, an authorized generic version of its Zanaflex capsules. Tizanidine HCl is a short-acting α2-adrenergic agonist indicated for the treatment of muscle spasticity. Due to its short duration of action, it is recommended that Tizanidine HCl capsules be reserved for those daily activities and times when relief of spasticity is most important.
Tizanidine HCl capsules are available from Watson in 2mg, 4mg, and 6mg dosage strength capsules.
For more information call (800) 272-5525 or visit www.watson.com.